• Molecular NamePenciclovir
  • SynonymPE2; Penciclovirum [INN-Latin]
  • Weight253.262
  • Drugbank_IDDB00299
  • ACS_NO39809-25-1
  • Show 2D model
  • LogP (experiment)-1.62
  • LogP (predicted, AB/LogP v2.0)-0.8
  • pkaN/A
  • LogD (pH=7, predicted)-0.8
  • Solubility (experiment)1.7 mg/ml
  • LogS (predicted, ACD/Labs)(ph=7)-1.52
  • LogSw (predicted, AB/LogsW2.0)3.62
  • Sw (mg/ml) (predicted, ACD/Labs)7.65
  • No.of HBond Donors5
  • No.of HBond Acceptors8
  • No.of Rotatable Bonds5
  • TPSA125.76
  • StatusFDA approved
  • AdministrationTopical
  • PharmacologyA guanine analogue antiviral drug used for the treatment of various herpesvirus infections.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability77.0
  • Protein binding20.0
  • Volume of distribution (VD)0.98 L/kg
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmViral thymidine kinase
  • Half life2 h
  • ExcretionRenal
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicitySymptoms of overdose include headache, abdominal pain, increased serum lipase, nausea, dyspepsia, dizziness, and hyperbilirubinemia.
  • LD50 (rat)N/A
  • LD50 (mouse)N/A